A photo of Chinese PLA navy fleet taken in April, 2018. [Photo/VCG] The Chinese military has put an end to 106,000 programs that aim to make profit by June 30, nearly achieving the goal of the three-year plan, the PLA Daily reported. The Central Military Commission said in a circular in March 2016 the military will gradually terminate all paid services in three years, and no new programs or contracts for paid services will be allowed. The circular stressed terminating all paid services was an important political task in building the armed forces, and urged units at all levels to fully implement the decision. The PLA Daily reported multiple military and government organs from the central to local level joined in the terminating work, and the country's top court and top procuratorate also provided support in the judicial field. According to the PLA report, there are still a few sensitive programs in procedures to end. A guideline was released on June 11 to further push ahead the work of ending all commercial activities before the end of this year. Contracts between the military and civilian entities that do not conclude by year's end should be terminated by that time through negotiation or legal procedures, it said, adding compensation will be provided for economic losses. In late 2015, China initiated a new round of military reforms. Ending paid services will help reduce corruption and create an enabling environment for the military to stick to its mission and improve its combat capacity. charity silicone wristbandsbat fidget spinnerjordan wristbandblack rubber wristbands
Young cancer patients undergo infusions at Beijing Children's Hospital. The number of children with cancer in China had reached 220,000 by 2014. [Ren Fangyan/For China Daily] Imported drugs are no longer subject to tariffs and VAT has been slashed in efforts to make medication more affordable, as Wang Xiaodong reports. The cost of imported cancer drugs is expected to fall dramatically as a result of recent government measures, according to the National Health Commission. On May 1, import tariffs were lifted on 103 of the 138 antineoplastic drugs - which can prevent or slow the growth of tumors - available on the Chinese market, and the value added tax levied on them was also reduced significantly. Authorities will also adopt measures to lower costs, such as price negotiations with manufacturers, greater use of centralized government procurement and the inclusion of a wider range of antineoplastic drugs in the national healthcare insurance program, Zeng Yixin, vice-minister in charge of the commission, told a media briefing last month. The moves are aimed at reducing the heavy financial burden that inadequate medical insurance cover can impose on some cancer patients, especially as the disease is a major cause of poverty in rural areas, the commission said. A report published last month by the Cancer Hospital at the Chinese Academy of Medical Sciences showed that more than 3.8 million new cases are reported in China every year. Cancer has become the leading threat to people's lives and health because of a number of causes - including the aging population, industrialization and unhealthy lifestyles - and the incidence of the disease is rising, Zeng said. Although new, effective antineoplastic drugs are available, some patented drugs are extremely expensive, and that places a heavy financial burden on patients.
